London: A "super" aspirin drug against cancer is on its way, say scientists, who claim that the pill doesn`t have usual side-effects like stomach ulcers.
A team at the City College of New York says that their research in mice has shown the compound, called NOSH aspirin, is effective in fighting, amongst others, cancers of the
colon, lung, breast, prostate, pancreas and blood.
The compound was found to shrink human colon cancer tumours implanted in mice by 85 per cent, "without adverse affects", they claim.
"The key components of this new compound are that it is very, very potent and yet it has minimal toxicity to the cells," Professor Khosrow Kashfi, lead author of the study, was quoted by `The Daily Telegraph` as saying.
A number of previous studies, led by Oxford University, indicate that long-term consumption of low dose (75mg a day) aspirin can reduce the chance of developing cetain cancers by up to half.
However, critics note that aspirin can cause serious stomach ulcers in some people, particularly the elderly. The US researchers have therefore been working to create
a version that does not harm the stomach lining and has much stronger anti-cancer qualities. They noted NOSH aspirin was still an experimental drug and clinical use in humans was "years away".
Experts have welcomed the findings to some extent. Dr Kat Arney of Cancer Research UK said: "It will be interesting to see how this particular compound progresses."
PTI
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookies Setting
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device and the processing of information obtained via those cookies (including about your preferences, device and online activity) by us and our commercial partners to enhance site navigation, personalise ads, analyze site usage, and assist in our marketing efforts. More information can be found in our Cookies and Privacy Policy. You can amend your cookie settings to reject non-essential cookies by clicking Cookie Settings below.
Manage Consent Preferences
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work or you may not be able to login.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They are also used to limit the number of times you see an advert as well as help measure the effectiveness of an advertising campaign. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we may not know when you have visited our site, and may not be able to monitor its performance.